Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Research Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.
The global exosome research market, valued at USD 189.07 million in 2022, is on the trajectory to achieve remarkable growth, with an anticipated compound annual growth rate (CAGR) of 13.71% by 2028. These statistics underscore a burgeoning sector fueled by an infusion of research and development funding, the climbing prevalence of cancer, and deepening interest within the medical community regarding exosome-based applications. Current technological advancements in exosome isolation and analysis are expected to catalyze this positive growth trajectory further.
The medical community's increasing awareness of the clinical potential of exosomes is propelling growth opportunities throughout the industry. This heightened awareness, in synergy with the surge in chronic diseases such as cancer, neurological, and cardiovascular disorders, drives demand for exosome-based diagnostics and therapeutics. Scientific studies underscore exosomes' innate ability to facilitate drug and genetic material delivery, positioning them at the forefront of transformative healthcare solutions.
The global exosome research market extends across various segments, including kits and reagents, instruments, and other products essential for exosomal research. These products play integral roles in applications ranging from biomarker discovery to vaccine development and tissue regeneration. Moreover, regional analysis indicates substantial activities across North America, Europe, Asia Pacific, South America, and the Middle East & Africa, reflecting the universal relevance of exosome research.
Market Dynamics
- Increased Funding: Spearheading advancements in the field, growing R&D funding is enabling progressive research into exosome biology and potential therapeutic interventions.
- Technological Breakthroughs: Pioneering isolation and analysis technologies have augmented the sensitivity and accuracy of exosome assays, unveiling new possibilities in diagnostics and treatment methodologies.
- Clinical Applications Recognition: The medical industry is witnessing burgeoning interest in exosome applications for a variety of health conditions, further igniting the market's growth momentum.
- Chronic Disease Prevalence: With chronic diseases on a steady rise globally, the imperative for novel therapeutic and diagnostic tools is stoking exosome research pursuits and market expansion.
Industry players are actively participating in this expanding market landscape, with major companies like Thermo Fisher Scientific, System Biosciences, Bio-Techne, and Lonza leading the innovation charge. The report offers a detailed competitive analysis of these key market players, outlining their contributions and strategic positions within the industry.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2022-2028 |
| Estimated Market Value (USD) in 2022 | $189.07 Million |
| Forecasted Market Value (USD) by 2028 | $404.19 Million |
| Compound Annual Growth Rate | 13.7% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes:
- Thermo Fisher Scientific
- System Biosciences
- Bio-Techne
- Lonza
- QIAGEN
- ExoDx
- Hitachi Chemical
- Aethlon Medical
- NanoSomiX
- Malvern Panalytical
- Sistemic Scotland Limited
- NX PharmaGen
For more information about this report visit https://www.researchandmarkets.com/r/i1aimi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
